OCP-S.A.
OCP S.A., a global leader in the fertilizer industry, will release its third quarter and nine month 2017 results on Thursday, November 30, 2017. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal at 9 a.m. EDT and 2 p.m. Morocco/London time.
OCP senior management will host a conference call to discuss 2017 third quarter/nine month results at 10 a.m. EDT and 3 p.m. Morocco/London time on Thursday, November 30, 2017 for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers.
Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma .
About OCP
OCP is a global leader in the fertilizer industry, backed by almost a century’s production history. OCP has exclusive access to the largest phosphate rock reserve base in the world. It is one of the lowest cost producers of phosphate rock in the industry and has become a leading player in production and trade volumes across the phosphate value chain. OCP employs 23,000 people and contributes to regional development through its mining and fertilizer operations, and through its sustainability program.
For more information visit: www.ocpgroup.ma .
View source version on businesswire.com: http://www.businesswire.com/news/home/20171122005486/en/
Contact:
OCP - Investor Relations
Ghita Laraki, +212 522 924 183
g.laraki@ocpgroup.ma
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GLOBAL-BLUE19.3.2024 13:20:30 CET | Press release
Reintroducing Global Blue to Retailers and Shoppers Worldwide
OH-FORGE-BIOLOGICS19.3.2024 13:01:30 CET | Press release
Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease is Granted UK’s Innovation Passport Designation
MAINSTAY-MEDICAL19.3.2024 13:01:29 CET | Press release
Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up
SWISSTO1219.3.2024 13:01:29 CET | Press release
SWISSto12 Continues Expansion, Growing Team by 25% and Adding New Production Space
CO-ANGLOGOLD-ASHANTI-PLC19.3.2024 12:05:35 CET | Press release
AngloGold Ashanti Releases Preliminary Unaudited Condensed Consolidated Financial Statements as of and for the Six Months and the Year Ended 31 December 2023
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom